Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir

Journal of Oral and Maxillofacial Surgery

Volumn 69, Issue 9, 2011, Pages 2383-2386

  Collette, David C ^a   Zechel, Marc A ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR;

ADULT; CASE REPORT; CHEEK MUCOSA; EPITHELIUM HYPERPLASIA; GINGIVA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN PAPILLOMAVIRUS ASSOCIATED EPITHELIAL HYPERPLASIA; HUMAN PAPILLOMAVIRUS-ASSOCIATED EPITHELIAL HYPERPLASIA; HUMAN TISSUE; MALE; MEDICAL HISTORY; MOUTH PAIN; ORAL BIOPSY; PAPILLOMAVIRUS INFECTION; REVIEW; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 80052096805     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2010.10.040     Document Type: Article

References (36)

1. J. Carr, and T. Gyorfi Human papillomavirus: Epidemiology, transmission, and pathogenesis Clin Lab Med 20 2000 235
2. J.E. Cameron, and M.E. Hagensee Oral HPV complications in HIV-infected patients Curr HIV/AIDS Rep 5 2008 126
3. A. Kreuter, N.H. Brockmeyer, and P. Altmeyer Anal intraepithelial neoplasia in HIV infection J Dtsch Dermatol Ges 6 2008 925
4. L. Ahdieh, R.S. Klein, and R. Burk Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women J Infect Dis 184 2001 682
5. E. De Clercq Therapeutic potential of cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections Verh K Acad Geneeskd Belg 58 1996 19
6. D. Calista Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 2000 713
7. B.A. Weaver Epidemiology and natural history of genital human papillomavirus infection J Am Osteopath Assoc 106 2006 S2
8. C.M. Wheeler Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer Obstet Gynecol Clin North Am 35 2008 519
9. F.X. Bosch, A.N. Burchell, and M. Schiffman Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia Vaccine 26 suppl 10 2008 K1
10. A.D. Varnai, M. Bollmann, and A. Bankfalvi The prevalence and distribution of human papillomavirus genotypes in oral epithelial hyperplasia: Proposal of a concept J Oral Pathol Med 38 2009 181
11. A.B. Moscicki, M. Schiffman, and S. Kjaer Chapter 5: Updating the natural history of HPV and anogenital cancer Vaccine 24 suppl 3 2006 42
12. A. de Jong, S.H. van der Burg, and K.M. Kwappenberg Frequent detection of human papillomavirus 16 E2-specific T helper immunity in healthy subjects Cancer Res 62 2002 472
13. A. de Jong, M.I. van Poelgeest, and J.M. van der Hulst Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6 Cancer Res 64 2004 5449
14. M.J. Welters, A. de Jong, and S.J. van den Eeden Frequent display of human papillomavirus type 16 E6-specific T-helper cells in the healthy population as witness of previous viral encounter Cancer Res 63 2003 636
15. M. Nakagawa, D.P. Stites, and S. Farhat Cytotoxic T lymphocyte responses to E6 and E7 proteins of human papillomavirus 16: Relationship to cervical intraepithelial neoplasia J Infect Dis 175 1997 927
16. M. Nakagawa, D.P. Stites, and S. Patel Persistence of human papillomavirus type 16 infections is associated with lack of cytotoxic T lymphocyte response to the E6 antigens J Infect Dis 182 2000 595
17. H.J. Bontkes, T.D. de Gruijl, and A.J. van den Muysenberg Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia Int J Cancer 88 2000 92
18. K.C. Cundy, G. Lynch, and W.A. Lee Bioavailability and metabolism of cidofovir following topical administration to rabbits Antivir Res 35 1997 113
19. X. Xiong, J.L. Smith, and M.S. Chen Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation Antimicrob Agents Chemother 41 1997 594
20. G. Andrei, R. Snoeck, and J. Piette Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines Oncol Res 10 1998 523
21. J.A. Johnson, and J.D. Gangemi Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2- (phosphonylmethoxy) propyl]cytosine Antimicrob Agents Chemother 43 1999 1198
22. R. Snoeck, G. Andrei, and E. De Clercq Cidofovir in the treatment of HPV-associated lesions Verh K Acad Geneeskd Belg 63 2001 93
23. W.C. Spanos, M. El-Deiry, and J.H. Lee Cidofovir incorporation into human keratinocytes with episomal HPV 16 results in nonselective cytotoxicity Ann Otol Rhinol Laryngol 114 2005 840
24. W.C. Spanos, M. El-Deiry, and J.H. Lee Cidofovir incorporation into human keratinocytes with episomal HPV 16 results in nonselective cytotoxicity Ann Otol Rhinol Laryngol 114 2005 840
25. Vistide (Cidofovir) [Package Insert] 2000 Gilead Sciences Foster City, CA
26. J.P. Lalezari, R.J. Stagg, and B.D. Kupperman Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: A randomized, controlled trial Ann Intern Med 126 1997 257
27. R. Snoeck, M. Bossens, and D. Parent Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection Clin Infect Dis 33 2001 597
28. L. Toutous-Trellu, B. Hirschel, and V. Piguet Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients Ann Dermatol Venereol 131 2004 445
29. B. Bienvenu, F. Martinez, and A. Devergie Topical use of cidofovir induced acute renal failure Transplantation 73 2002 661
30. A.J. Donne, L. Hampson, and X.T. He Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease Antivir Ther 14 2009 939
31. G. Coremans, V. Margaritis, and R. Snoeck Topical cidofovir (HPMPC) is an effective adjuvant to surgical treatment of anogenital condylomata acuminata Clin Infect Dis 46 2003 1103
32. D. Calista Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS: A pilot study J Eur Acad Dermatol Venereol 14 2000 484
33. C. Martinelli, A. Farese, and A.D. Mistro Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection J Eur Acad Dermatol Venereol 15 2001 568
34. I. Stragier, R. Snoeck, and E. De Clercq Local treatment of HPV-induced skin lesions by cidofovir J Med Virol 67 2002 241
35. H. Bonatti, F. Aigner, and E. De Clercq Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients Transpl Int 20 2007 238
36. D. Beaulieu, M. Burnouf, and F. Plantier Extensive oral condylomas treated by in situ cidofovir injection in an HIV patient Ann Dermatol Venereol 135 2008 307